Should You Have this stock in Your Portfolio? Unity Biotechnology (UBX)

Unity Biotechnology (UBX) Stock’s Moving Average & Performance Analysis:

The stock showed weekly performance of -9.44% and it maintained for the month at -37.20%. Likewise the performance for the quarter was recorded as -16.93%. The YTD performance remained at -24.56%. This stock traded higher toward its 52 week low with 10.08% and -48.86% downward from its 52 week high price. The stock price is moving down from its 20 days moving average with -22.33% and it is trading down from 50 days moving average with -24.53%. The stock price is moving along negative drift from its 200 days moving average with -19.50%.

Let’s consider Unity Biotechnology (UBX) stock move that changed on Friday Dated OCTOBER 12, 2018. 152102 shares changed at hands in last session versus to an average volume of 145.68K shares. Unity Biotechnology (UBX) stock ended at $12.56 by scoring 9.12%. It has 43.93M outstanding shares and 37.94M shares have been floated in market exchange. The stock institutional ownership included 30.40% while insider ownership remained 8.00%. The net percent change held by Institutional Investors has seen a change of 0.01% over last three month period.

Stock’s Price Fluctuations & Volatility:

The stock price registered volatility 9.34% in past week and volatility was at 9.37% over a last month. Historical volatility refers to the price fluctuations exhibited by the underlying asset (such as stock) over time. A security with high volatility has bigger fluctuations in price compared to a security with low volatility. The more quickly a price changes up and down, the more volatile it is. As such, volatility is often used as a measure of risk.

The stock’s Average True Range for 14 days was 1.42. ATR measures volatility, taking into account any gaps in the price movement. High ATR indicates increased volatility. A low ATR value indicates a series of periods with small ranges.

Presently, Unity Biotechnology (UBX) has a RSI reading of 35.67.

Stock’s Ratio Analysis:

It has kept Return on investment (ROI) at 54.90%. ROI is a financial ratio intended to measure the benefit obtained from an investment. Time is usually of the essence in this measurement because it takes time for an investment to realize a benefit.

Long Term Debt/Equity ratio was recorded at 0. This measures a company’s financial leverage calculated by dividing its long term debt by stockholders’ equity. It indicates what proportion of equity and debt the company is using to finance its assets. On the other side the debt to equity ratio is 0. Its current ratio is 19.9. Current Ratio is a liquidity ratio that measures a company’s ability to pay short-term obligations. Quick Ratio of 19.9 is an indicator of a company’s short-term liquidity. The quick ratio measures a company’s ability to meet its short-term obligations with its most liquid assets. The higher the quick ratio, the better the position of the company.

Mark Fife

Mark Fife

Mark Fife has an experience in Journalism and Content Writing, love writing stories full of efficient language and accurate content. He is a graduate of University of Sydney and has two years’ experience of Wall Street Investor. Mark covers Business category. His articles are published on Seeking Alpha, The Street, and The Motley Fool. Brianna has over 4 year experience as a news writer. Previously, he worked as a tech news reporter. Email Contact: Mark@connectinginvestor.com

Leave a Reply

Your email address will not be published. Required fields are marked *